EUVIMEDEUVIMED entdecken
Crossref

Development of the prognostic value in lung adenocarcinoma based on anoikis‐related genes and initial experimental validation

Wenwei Guo, Guang Zhao iD, Suping Liu, Tao Deng, Guangjian Zhang, Boxiang Zhang

The Journal of Gene Medicine · 2023

DOI: 10.1002/jgm.3534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2023. Verfasst von Wenwei Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung adenocarcinoma (LUAD) is a highly aggressive cancer in advanced stages and has the highest cancer‐related death across the world. Anoikis has emerged as a specific form of apoptotic cell death that may play a vital role in the formation and development of tumors.

Methods

Based on The Cancer Genome Atlas dataset, we developed a novel anoikis‐related genes (ARGs) signature in LUAD and evaluated the differences between low and high‐risk groups in clinical characteristics, expression patterns, immune cell infiltration, and drug sensitivity, etc. According to multivariate Cox regression analysis, the risk score was identified as a significant independent prognostic factor. The possible biological pathways of ARGs' were assessed by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses. The immune infiltration landscape and risk score of ARGs were analyzed by ESTIMATE and CIBERSORT analysis. A nomogram grounded on six key ARGs and clinicopathological features was provided. Moreover, experiment validation of the expression patterns of six hub ARGs in lung cancer cell lines was conducted.

Results

We identified 53 survival‐related LUAD anoikis‐related differentially expressed genes and finally six hub anoikis genes (LDHA, SLC2A1, SERPINB5, ITGB4, BRCA2, and PIK3R1) were selected to construct an ARG model. The risk model could efficiently cluster the patients into low‐ and high‐risk groups which could accurately predict clinical outcomes for LUAD patients. There is evidence that the prognostic risk score is a remarkable prognostic factor in determining overall survival. Different immune statuses and drug sensitivity between low‐ and high‐risk groups were explored according to functional analysis. On the basis of risk scores and LUAD clinicopathological features, a novel nomogram was developed. Ultimately, all six key genes except for PIK3R1 were proved to be upregulated in LUAD tissues and cell lines by bioinformatics analysis and experimental validation.

Conclusions

The result of the present study suggest that ARGs could be carcinogenic to LUAD and could be used as an effective stratification factor to customize therapies and forecast the survival rate in LUAD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsAdenocarcinomaHumansPrognosisAnoikisTranscription Factors

Stichwörter der Autor:innen

anoikisbioinformatics analysisexperimental validationlung adenocarcinomanon-small cell lung cancerprognosis

Substanzen

Transcription Factors

Autor:innen und Institutionen

  • Department of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Department of Cardiothoracic Surgery, Ji 'an Central People's Hospital, Ji'an, China.
  • Department of Rehabilitation Medicine, Ji'an Central People's Hospital, Ji'an, China.
  • Department of Pain, Ji 'an Central People's Hospital, Ji'an, China.

ORCID-Profile: Guang Zhao

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shaanxi Province

Zitieren

APA

Guo, W., Zhao, G., Liu, S., Deng, T., Zhang, G., & Zhang, B. (2023). Development of the prognostic value in lung adenocarcinoma based on anoikis‐related genes and initial experimental validation. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.3534

Vancouver

Guo W, Zhao G, Liu S, Deng T, Zhang G, Zhang B. Development of the prognostic value in lung adenocarcinoma based on anoikis‐related genes and initial experimental validation. The Journal of Gene Medicine. 2023. doi:10.1002/jgm.3534

BibTeX
@article{Guo2023,
  author = {Guo, Wenwei and Zhao, Guang and Liu, Suping and Deng, Tao and Zhang, Guangjian and Zhang, Boxiang},
  title = {Development of the prognostic value in lung adenocarcinoma based on anoikis‐related genes and initial experimental validation},
  journal = {The Journal of Gene Medicine},
  year = {2023},
  doi = {10.1002/jgm.3534}
}
Kostenlos starten →